Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 28(3) 383-390 2021年7月 [査読有り]
OBJECTIVES: In Japan, most tuberculosis (TB) cases occur among individuals aged 65 years or older. However, data on in-hospital adverse events (AEs) associated with TB management, especially in high-income nations with an ageing population, are sc...
Infection Control & Hospital Epidemiology 42(6) 1-5 2021年6月 [査読有り]
<title>Abstract</title>A questionnaire was distributed to hospitals in Tokyo (N = 38) regarding their preparedness against and in-facility transmission of coronavirus disease 2019 (COVID-19). As of May 31, 2020, 284 HCP had contracted COVID-19, an...
Open forum infectious diseases 8(6) ofab125 2021年6月 [査読有り]
Background: The present study assessed the impact of time-out on vancomycin use and compared the strategy's efficacy when led by pharmacists versus infectious disease (ID) physicians at a tertiary care center. Methods: Time-out, consisting of a te...
François-Xavier Lescure   Hitoshi Honda   Robert A Fowler   Jennifer Sloane Lazar   Genming Shi   Peter Wung   Naimish Patel   Owen Hagino   
The Lancet Respiratory medicine 9(5) 522-532 2021年5月 [査読有り]
BACKGROUND: Elevated proinflammatory cytokines are associated with greater COVID-19 severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, in patients with severe (requiring supplemental oxygen by nasal...